Congresso

SynBioBeta 2025

maio 5 - 8, 2025

San Jose, California

United States

About the Event

SynBioBeta is more than just a conference; it is a comprehensive innovation network that brings together a diverse community of biological engineers, innovators, entrepreneurs, and investors, all united by a shared vision of leveraging biology to create a better and more sustainable world.

This year, from May 5–8, we will gather in San Jose to connect, learn and create. We’ll be in Booth 301—we look forward to seeing you!

Tools to Build a Better Tomorrow

By the end of the century, the world’s population is expected to reach 10 billion.1 Synthetic biology will play an integral role in supporting this population growth. 

At SynBioBeta 2025, we’ll be introducing you to solutions that can help you:

  • Increase the speed of gene assembly and synthetic protein testing
  • Automate plasmid preparation for speed and data consistency
  • Precisely control and evaluate up to 48 parallel microbial growth conditions on a single plate
  • Reduce assay volumes and consumables use
  • Screen microbial strains, cultivation media and bioprocess conditions faster

 

We’re also excited to chat with you about why our commitment to sustainability matters and what it means for you. For us, it’s all about keeping the long-term interests of our associates, customers, shareholders, business partners, communities, and the planet at the heart of everything we do.

Breakout Session

Accelerating Biomanufacturing Through On-Demand Synthesis

Tuesday, May 6 | 4:30–5:15 p.m. | GSBC25062

Moderator:


Maria Savino,
Global Segment Development Manager,
Beckman Coulter Life Sciences

Panelists:


Huimin Zhao,
Steven L. Miller Chair of Chemical and Biomolecular Engineering at UIUC, Director of NSF AI Institute for Molecule Synthesis, and Editor-in-Chief of ACS Synthetic Biology

 


Krishna Kannan,
Vice President of Product Development, Telesis Bio

On Tuesday, May 6, Maria Savino, Global Segment Development Manager at Beckman Coulter Life Sciences, will moderate a discussion on accelerating biomanufacturing through on-demand synthesis. This innovative approach leverages nucleic acid development from Telesis Bio and protein production from the Illinois Biological Foundry for Advanced Biomanufacturing. These thought leaders will discuss the streamlined and enhanced efficiency of producing complex biological molecules when integrating their advanced technologies, transforming the landscape of synthetic biology.

   

References

1. https://www.un.org/en/desa/world-population-projected-reach-98-billion-2050-and-112-billion-2100

Products and demonstrated applications are not intended or validated for use in diagnostic procedures.
ECHO is a trademark or registered trademark of Labcyte Inc. in the United States and other countries. Labcyte is a Beckman Coulter company.